| Primary |
| Osteoporosis |
50.0% |
| Parkinson's Disease |
25.0% |
| Urinary Retention |
25.0% |
|
| Respiratory Tract Infection |
100.0% |
|
| Secondary |
| Hypertension |
21.0% |
| Product Used For Unknown Indication |
19.3% |
| Type 2 Diabetes Mellitus |
13.4% |
| Hiv Infection |
7.6% |
| Cardiac Failure |
6.7% |
| Diabetes Mellitus |
5.0% |
| Atrial Fibrillation |
3.4% |
| Hypokalaemia |
3.4% |
| Malaria |
3.4% |
| Depression |
2.5% |
| Hypothyroidism |
2.5% |
| Angina Pectoris |
1.7% |
| Bacterial Infection |
1.7% |
| Chronic Obstructive Pulmonary Disease |
1.7% |
| Haemorrhoids |
1.7% |
| Infection Prophylaxis |
1.7% |
| Arrhythmia |
0.8% |
| Chemotherapy |
0.8% |
| Constipation |
0.8% |
| Diarrhoea |
0.8% |
|
| Pancreatic Carcinoma Metastatic |
10.3% |
| Somnolence |
10.3% |
| Mixed Liver Injury |
6.9% |
| Pulmonary Arterial Hypertension |
6.9% |
| Renal Failure Acute |
6.9% |
| Thirst |
6.9% |
| Vomiting |
6.9% |
| Arthralgia |
3.4% |
| Cardiac Failure |
3.4% |
| Convulsion |
3.4% |
| Dehydration |
3.4% |
| Dermatitis Exfoliative |
3.4% |
| Diarrhoea |
3.4% |
| Dyspnoea Exertional |
3.4% |
| Haematoma |
3.4% |
| Hypovolaemic Shock |
3.4% |
| Inappropriate Antidiuretic Hormone Secretion |
3.4% |
| Palpitations |
3.4% |
| Paroxysmal Arrhythmia |
3.4% |
| Polyneuropathy |
3.4% |
|
| Concomitant |
| Drug Use For Unknown Indication |
25.5% |
| Product Used For Unknown Indication |
24.7% |
| Hypertension |
9.8% |
| Prophylaxis |
4.7% |
| Pain |
4.3% |
| Rheumatoid Arthritis |
3.2% |
| Multiple Myeloma |
3.1% |
| Type 2 Diabetes Mellitus |
3.1% |
| Premedication |
2.8% |
| Atrial Fibrillation |
2.4% |
| Hypokalaemia |
2.3% |
| Diabetes Mellitus |
2.1% |
| Hepatitis C |
2.1% |
| Anxiety |
1.5% |
| Epilepsy |
1.5% |
| Hiv Infection |
1.5% |
| Constipation |
1.4% |
| Depression |
1.4% |
| Pain Prophylaxis |
1.4% |
| Bronchial Carcinoma |
1.3% |
|
| Renal Failure Acute |
12.3% |
| Vomiting |
11.5% |
| Thrombocytopenia |
9.0% |
| Malaise |
4.9% |
| Pancytopenia |
4.9% |
| Pulmonary Embolism |
4.9% |
| Sepsis |
4.9% |
| Renal Failure |
4.1% |
| Renal Failure Chronic |
4.1% |
| Somnolence |
4.1% |
| Status Epilepticus |
4.1% |
| Toxic Skin Eruption |
4.1% |
| Weight Increased |
4.1% |
| Arthritis Infective |
3.3% |
| Clostridium Difficile Colitis |
3.3% |
| Hypoglycaemia |
3.3% |
| International Normalised Ratio Increased |
3.3% |
| Lung Disorder |
3.3% |
| Shock Haemorrhagic |
3.3% |
| Urinary Tract Infection |
3.3% |
|
| Interacting |
| Hypertension |
60.0% |
| Atrial Fibrillation |
20.0% |
| Diabetes Mellitus |
20.0% |
|
| Renal Failure Acute |
100.0% |
|
